Company: BLLN
Filing Date: 2025-10-07
Form Type: S-1
Source: 0001193125-25-233697
Chunk: 96

Company: BillionToOne, Inc.
Filing Date: 2025-10-07
Form: S-1
Chunk 96
---
 regulations may include, among others:

| • |     | the federal Anti-Kickback Statute (AKS), which prohibits knowingly and willfully offering, paying, soliciting or receiving                                                                                                                      
 remuneration, directly or indirectly, overtly or covertly, in cash or in kind (e.g. provision of free or discounted goods, services or items), in exchange for or to induce either the referral of an individual for, or the purchase, order or 
 recommendation of, any good or service for which payment may be made under federal health care programs, such as Medicare, unless a safe harbor applies;                                                                                        |

| • |     | the federal Eliminating Kickbacks in Recovery Act (EKRA), which prohibits knowingly and willfully soliciting or receiving                                                                                                                            
 any remuneration (including any kickback, bribe or rebate) directly or indirectly, overtly or covertly, in cash or in kind, in return for referring a patient or patronage to a laboratory; or paying or offering any remuneration (including any    
 kickback, bribe or rebate) directly or indirectly, overtly or covertly, in cash or in kind, to induce a referral of an individual to a laboratory or in exchange for an individual using the services of that laboratory billed to either commercial 
 third-party payors or government payors;                                                                                                                                                                                                             |

| • |     | the Stark Law and similar state laws, which prohibits a physician from making a referral for certain designated health                                                                                                                                   
 services covered by the Medicare or Medicaid program, including laboratory and pathology services, if the physician or an immediate family member of the physician has a financial relationship with the entity providing the designated health services 
 and prohibits that entity from billing, presenting or                                                                                                                                                                                                    |

59

| causing to be presented a claim for the designated health services furnished pursuant to the prohibited referral, unless an exception applies; |

| • |     | the federal Civil Monetary Penalties Law, which prohibits, among other things, the offering or transfer of remuneration to                                                                                                                     
 a Medicare or state healthcare program beneficiary if the person knows or should know it is likely to influence the beneficiary’s selection of a particular provider, practitioner or supplier of services reimbursable by Medicare or a state 
 healthcare program, unless an exception applies;                                                                                                                                                                                               |

| • |     | federal and state “Anti-Markup” rules, which, among other things, typically prohibit a physician or supplier                                                                                                                       
 billing for molecular diagnostic tests (with certain exceptions) from marking up